Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 189 entries
View as:

A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)

Phase: N/A Priority: Normal
NCT ID: NCT03474107 Org: User:
Start: 06/27/18 End: 08/31/25 Due: 08/31/26

A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of ASP2215

Phase: N/A Priority: Normal
NCT ID: NCT02571816 Org: User:
Start: 10/23/15 End: 03/05/16 Due: 03/05/17

A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03288545 Org: User:
Start: 10/11/17 End: 09/11/26 Due: 09/11/27

A Study to Assess the Analgesic Efficacy and Safety of ASP8062 in Subjects With Fibromyalgia

Phase: N/A Priority: Normal
NCT ID: NCT03092726 Org: User:
Start: 05/08/17 End: 03/06/18 Due: 03/06/19

A Study to Assess the Safety, Tolerability and Immunological Response of ASP2390 in Adult Subjects Allergic to House Dust Mites

Phase: N/A Priority: Normal
NCT ID: NCT04184895 Org: User:
Start: 09/09/20 End: 12/31/26 Due: 12/31/27

A Study to Evaluate Tolerability and Participants Preference Between Mirabegron and Tolterodine Extended Release (ER) in Participants With Overactive Bladder (OAB)

Phase: N/A Priority: Normal
NCT ID: NCT02138747 Org: User:
Start: 07/24/14 End: 11/11/15 Due: 11/11/16

A Study to Evaluate Safety, Tolerability and Immune Response in Adults Allergic to Peanut After Receiving Intradermal or Intramuscular Administration of ASP0892 (ARA-LAMP-vax), a Single Multivalent Peanut (Ara h1, h2, h3) Lysosomal Associated Membrane Protein DNA Plasmid Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT02851277 Org: User:
Start: 12/13/16 End: 12/06/18 Due: 12/06/19

A Study of Gilteritinib (ASP2215) Combined With Chemotherapy in Children, Adolescents and Young Adults With FMS-like Tyrosine Kinase 3 (FLT3)/Internal Tandem Duplication (ITD) Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)

Phase: N/A Priority: Normal
NCT ID: NCT04240002 Org: User:
Start: 09/04/20 End: 03/17/25 Due: 03/17/26

A Study to Find a Suitable Dose of ASP8731 and Check for Medical Problems at Each Dose in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT05167526 Org: User:
Start: 03/07/22 End: 11/10/22 Due: 11/10/23

A Study of ASP8273 in Subjects With Non-small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR) Mutations

Phase: N/A Priority: Normal
NCT ID: NCT03082300 Org: User:
Start: 03/24/17 End: 06/19/17 Due: 06/19/18

Rollover Study for Subjects Who Have Participated in an Astellas Sponsored ASP2215 Trial

Phase: N/A Priority: Normal
NCT ID: NCT02561455 Org: User:
Start: 05/03/16 End: 07/28/20 Due: 07/28/21

A Study to Evaluate Escalating Doses of ASP1235 (AGS62P1) Given as Monotherapy in Subjects With Acute Myeloid Leukemia (AML)

Phase: N/A Priority: Normal
NCT ID: NCT02864290 Org: User:
Start: 11/10/16 End: 09/03/20 Due: 09/03/21

A Rollover Study for Subjects That Have Participated in an Astellas Sponsored Linsitinib Trial

Phase: N/A Priority: Normal
NCT ID: NCT02057380 Org: User:
Start: 04/16/14 End: 12/21/16 Due: 12/21/17

Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP1617 in Healthy Adult Non-Asian and Japanese Subjects Including Assessment of a Food Effect

Phase: N/A Priority: Normal
NCT ID: NCT04077879 Org: User:
Start: 09/19/19 End: 06/12/21 Due: 06/12/22

Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)

Phase: N/A Priority: Normal
NCT ID: NCT02380274 Org: User:
Start: 03/27/15 End: 01/14/21 Due: 01/14/22

A Study to Assess Isavuconazole Following a Single Dose of Isavuconazonium Sulfate Intravenous Solution Via Nasogastric (NG) Tube Compared to a Single Dose of Oral Capsules Under Fasting Conditions in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04096157 Org: User:
Start: 09/24/19 End: 01/16/20 Due: 01/16/21

Dose Escalation Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of ASP2215 in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT02014558 Org: User:
Start: 10/09/13 End: 03/07/18 Due: 03/07/19

A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03816163 Org: User:
Start: 03/15/19 End: 08/31/26 Due: 08/31/27

A Study To Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of ASP2408 After Multiple Dose Subcutaneous Injections in Patients With Rheumatoid Arthritis on Methotrexate

Phase: N/A Priority: Normal
NCT ID: NCT02052375 Org: User:
Start: 06/30/12 End: 12/31/13 Due: 12/31/14

A Study to Assess the Safety and Efficacy of ASP8062 as an Add-on Therapy to Buprenorphine/Naloxone in Participants With Opioid Use Disorder

Phase: N/A Priority: Normal
NCT ID: NCT05062577 Org: User:
Start: 11/08/21 End: 02/28/23 Due: 02/28/24

A Study of Zolbetuximab With Chemotherapy in Adults With Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06396091 Org: User:
Start: 07/22/24 End: 07/03/26 Due: 07/03/27

Treatment Patterns and Key Healthcare Resource Use in Acute Myeloid Leukemia (AML) With or Without FMS-like Tyrosine Kinase-3 (FLT3) Mutation Study Based on Retrospective Chart Review

Phase: N/A Priority: Normal
NCT ID: NCT03047083 Org: User:
Start: 06/02/14 End: 03/18/16 Due: 03/18/17

A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Methotrexate

Phase: N/A Priority: Normal
NCT ID: NCT01884636 Org: User:
Start: 02/28/13 End: 03/31/13 Due: 03/31/14

A Study of ASP0367 in People With Kidneys That do Not Work Well and in Healthy People

Phase: N/A Priority: Normal
NCT ID: NCT05117294 Org: User:
Start: 12/21/21 End: 11/22/22 Due: 11/22/23

A Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)

Phase: N/A Priority: Normal
NCT ID: NCT02677896 Org: User:
Start: 03/09/16 End: 07/31/24 Due: 07/31/25